Propanc Biopharma

Recent Finacing

Series C

Recent Raise

$1M

Propanc Biopharma is an Australian biotechnology company developing pancreatic proenzyme-based therapies to prevent the recurrence and metastasis of solid tumors.

Victoria, Australia

1-10

Publicly Traded

propanc.com